Coastline Trust CO Gilead Sciences, Inc. Transaction History

Coastline Trust CO

$847 Million
Q3 2024

A detailed history of Coastline Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Coastline Trust CO holds 1,460 shares of GILD stock, worth $131,677. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,460

Holding current value

$131,677

% of portfolio

0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$66.59 - $83.99 $97,221 - $122,625	1,460 New	1,460 $122,000
Q4 2023 Jan 23, 2024	SELL	$73.27 - $83.09 $32,971 - $37,390	-450 Reduced 10.39%	3,880 $314,000
Q3 2023 Oct 17, 2023	SELL	$73.94 - $80.67 $37,709 - $41,141	-510 Reduced 10.54%	4,330 $324,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $367,888 - $419,628	4,840 New	4,840 $373,000
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $150,814 - $216,517	2,420 New	2,420 $207,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $264,555 - $301,448	-4,670 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $13,041 - $16,396	210 Added 4.71%	4,670 $295,000
Q2 2020 Aug 07, 2020	BUY	$72.34 - $84.0 $33,276 - $38,640	460 Added 11.5%	4,460 $343,000
Q1 2020 Jun 10, 2020	BUY	$62.63 - $80.22 $250,520 - $320,880	4,000 New	4,000 $299,000
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $201,594 - $222,525	-3,225 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $201,659 - $225,911	3,225 New	3,225 $210,000
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $1.43 Million - $1.87 Million	-23,655 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$71.28 - $78.92 $462,607 - $512,190	6,490 Added 37.81%	23,655 $1.83 Million
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $200,479 - $233,851	3,090 Added 21.95%	17,165 $1.22 Million
Q1 2018 Apr 16, 2018	BUY	$72.84 - $88.8 $214,878 - $261,960	2,950 Added 26.52%	14,075 $1.06 Million
Q4 2017 Jan 17, 2018	BUY	$71.15 - $83.52 $152,261 - $178,732	2,140 Added 23.82%	11,125 $797,000
Q3 2017 Nov 17, 2017	BUY	$72.11 - $85.47 $206,234 - $244,444	2,860 Added 46.69%	8,985 $728,000
Q2 2017 Aug 10, 2017	BUY	N/A	6,125	6,125 $434,000

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.

Account